PPH – Part 2 The role of Viscoelastic hemostatic assays for PPH management

n a previous interview (PPH part 1) with Dr. Michaela Farber, we discussed the importance of fibrinogen concentrate. During this interview, Dr. Collis and Dr. Bell help us understand the importance of early recognition of hypofibrinogenemia and replacement of this important coagulation factor. Our guests have over a decade of experience using viscoelastic hemostatic assays (VHA) and implementing algorithms to help guide early recognition and prompt fibrinogen replacement. Here are the links to the papers discussed during the interview- https://pubmed.ncbi.nlm.nih.gov/30322667/ https://pubmed.ncbi.nlm.nih.gov/25024304/ - OBS1 https://pubmed.ncbi.nlm.nih.gov/28969312/ - OBS2 https://pubmed.ncbi.nlm.nih.gov/25586727/ https://pubmed.ncbi.nlm.nih.gov/22805300/ https://pubmed.ncbi.nlm.nih.gov/26683982/ https://pubmed.ncbi.nlm.nih.gov/25064078/ https://pubmed.ncbi.nlm.nih.gov/17087729/ https://pubmed.ncbi.nlm.nih.gov/36696216/